Scott M. Pittman Increases Stake in Nuo Therapeutics via Debt Financing and Warrant Issuance

On June 3, 2026, Scott M. Pittman filed Amendment No. 4 to his Schedule 13D for Nuo Therapeutics, Inc. (AURX), reporting an increased beneficial ownership of 5,627,500 shares, representing 11.6% of the company. This change stems from an Interim Closing on May 29, 2026, under an Amended and Restated Loan and Security Agreement. During this transaction, Pittman loaned an additional $100,000 to the company, bringing his total loan commitment to $300,000. In connection with the financing, Pittman was issued new Interim Warrants immediately exercisable for 17,450 shares of common stock. His total beneficial ownership includes 5,400,000 shares held directly, 47,500 shares issuable upon the exercise of vested warrants, and 180,000 shares issuable upon the exercise of options. The filing also details the issuance of various conditional and restated warrants, including those for potential future funding and interest payments. The warrants have an exercise price of $1.50 per share and expire in January 2030.